(Q37146091)

18 August 2017

1 reference

title

The prognostic value of the ECG in hypertension: where are we now? (English)

1 reference

18 August 2017

main subject

arterial hypertension

0 references

author name string

Dsc Ang

series ordinal

1

1 reference

18 August 2017

Cc Lang

series ordinal

2

1 reference

18 August 2017

publication date

24 April 2008

1 reference

Journal of Human Hypertension

18 August 2017

published in

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

460-467

1 reference

Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

A point-score system for the ECG diagnosis of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Improved electrocardiographic diagnosis of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Improved cardiovascular risk stratification by a simple ECG index in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prognostic value of electrocardiographic criteria for left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prevalence and natural history of electrocardiographic left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prognostic Impact of Prolonged Ventricular Repolarization in Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Prognostic significance of serial changes in left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.24

7 January 2021

Identifiers

DOI

10.1038/JHH.2008.24

1 reference

18 August 2017

1 reference